Physician Social Networkers are High Prescribers and More Likely to Engage with Pharma

Manhattan ResearchManhattan Research, a global pharmaceutical and healthcare market research company, releases its latest physician analysis titled "Physician Online Communities: Physician Social Networking and the New Online Opinion Leaders" as part of the Taking the Pulse® physician market research and strategic advisory service. This analysis provides in-depth market data and charts on the key demographics, behaviors, pharma company interactions, and specialty-specific differences of those currently using or interested in using physician online communities. It also details how physicians are engaging in online communities and opportunities for pharma to incorporate this channel into their brand strategies.

According to the analysis, physicians currently participating in online physician communities should be of particular interest to pharma - as they write a mean of twenty-four more prescriptions per week than physicians with no interest in online physician communities. Additionally, the majority of physicians report that they expect pharma to monitor professional community sites and view this monitoring as a positive undertaking.

"With about 60% of physicians already using or interested in using physician online communities, it's the right time for pharma to look into the marketing and research opportunities offered by this channel," said Erika S. Fishman, author of the analysis and Director of Research at Manhattan Research. "Physician networkers' high prescribing rates and willingness to engage with pharma make them a valuable group to court."

Analysis Outline

Physician Online Communities: Physician Social Networking and the New Online Opinion Leaders

Who Is Using Physician Communities?

Physician Communities

  • Sermo
  • Medscape Physician Connect
  • Other Physician-only Online Communities
    • Specialty-specific Online Communities
    • Student and Resident Online Communities
  • Physician Communities within Social Networking Sites

What Does This Mean for Pharma and Others in the Healthcare Industry?

  • Sermo for the Client
  • Medscape Physician Connect for the Client
  • Physician Opinion Regarding Pharma Involvement in Communities

Key Takeaways

For an excerpt from the analysis and more information about its contents, please visit: http://www.manhattanresearch.com/products/Research_Modules
/Physician/physician-online-communities.aspx

Accessing the "Physician Online Communities" analysis is immediately available to subscribers of Manhattan Research's Taking the Pulse® v8.0 market research and strategic advisory service. For more information about becoming a subscriber to this service and gaining access to the in-depth physician market data and analysis, visit http://www.manhattanresearch.com/products/Strategic_Advisory
/ttp/default.aspx

About Taking the Pulse® v8.0
Taking the Pulse® v8.0 is a physician study and strategic advisory service focused on how physicians use the Internet and technology in their practice and its impact on treatment decisions. Overall physician market data can be segmented into analysis of over 25 specialties. For more information, visit http://www.manhattanresearch.com/products/Strategic_Advisory/ttp/default.aspx

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...